Evidence map›Paper›PMID 38137662›Full record

ArticleJournal of clinical medicine2023

Preliminary Outcomes of Zone 2 Thoracic Endovascular Aortic Repair Using Castor Single-Branched Stent Grafts: A Single-Center Experience.

Antonio Rizza, Giancarlo Trimarchi, Silvia Di Sibio, Luca Bastiani, Michele Murzi, Cataldo Palmieri, Ilenia Foffa, Sergio Berti

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. An Initial Single-Center European Experience with the Gore Thoracic Branch Endoprosthesis.Interdisciplinary cardiovascular and thoracic surgery · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Antonio RizzaFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.ORCID 0000-0002-0755-4933
Giancarlo TrimarchiDepartment of Clinical and Experimental Medicine, University Hospital of Messina, 98121 Messina, Italy.ORCID 0009-0008-9165-7732
Silvia Di SibioFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.
Luca BastianiFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.
Michele MurziFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.
Cataldo PalmieriFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.
Ilenia FoffaFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.
Sergio BertiFondazione Toscana Gabriele Monasterio, 54100 Massa, Italy.ORCID 0000-0002-5244-0556
Fondazione Toscana Gabriele Monasterio · ITIstituto di Fisiologia Clinica · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the context of thoracic endovascular aortic repair (TEVAR), the reconstruction of the left subclavian artery (LSA) has emerged as a crucial component in establishing a sufficient proximal landing zone. However, the technical difficulty of these procedures raises the possibility of endoleaks and neurological consequences. Single-branched stent grafts offer good anchoring and LSA flow for these patients. This study evaluates the feasibility of utilizing novel single-branched stent grafts in the treatment of distal aortic arch disease, identifying good results in the short and medium term. From September 2019 to March 2023, TEVAR and revascularized LSA were performed on ten patients at the Ospedale del Cuore-FTGM in Massa, Italy, using Castor single-branched thoracic aortic stent grafts (Microport Medical, Shanghai, China). The authors' first findings demonstrated that, after an average follow-up of one year, the Castor branching aortic stent graft system was safe and achieving an appropriate proximal landing zone and maintaining sufficient LSA perfusion was possible. With regard to the endovascular treatment of distal aortic arch diseases, this product offers a compelling substitute for surgery. For the purpose of assessing the long-term effectiveness of this approach, the follow-up period should be extended.

Indexed as

aortic arch pathologiesendovascular approachsafetysingle-branched stent grafttype B aortic dissections

Identifiers

PMID38137662
PMCPMC10743804
OpenAlexW4389538062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.